E88.42 MERRF syndrome

Name of the Condition

• MERRF syndrome (Myoclonic Epilepsy with Ragged-Red Fibers)
• ICD-10 Code: E88.42

Summary

MERRF syndrome is a rare mitochondrial disorder characterized by myoclonus (sudden, involuntary muscle jerks), epilepsy, and progressive neurological decline. It often involves muscle weakness and the presence of ragged-red fibers in muscle biopsies, reflecting mitochondrial dysfunction.

Causes

MERRF is primarily caused by mutations in mitochondrial DNA, most commonly in the MT-TK gene. These mutations impair mitochondrial protein synthesis and energy production, leading to cellular dysfunction.

Risk Factors

• Maternal inheritance, as mitochondria are passed from mother to offspring.
• Family history of mitochondrial disorders increases susceptibility.

Symptoms

• Myoclonic seizures (sudden, shock-like muscle jerks).
• Progressive muscle weakness and ataxia (loss of coordination).
• Hearing loss and vision problems.
• Cognitive decline and dementia in advanced stages.

Diagnosis

Diagnosis combines clinical evaluation, electromyography (EMG) to detect myoclonus, muscle biopsy (showing ragged-red fibers), and genetic testing to identify mitochondrial DNA mutations.

Treatment Options

Management focuses on symptom control. This may include antiseizure medications, physical therapy for muscle strength, and supportive care for neurological symptoms. No cure exists.

Prognosis and Follow-Up

Prognosis varies; symptoms often progress over time, leading to increasing disability. Regular neurological and cardiac monitoring is recommended to address complications.

Complications

• Severe neurological impairment.
• Cardiac arrhythmias or other organ dysfunction due to mitochondrial failure.
• Respiratory issues from muscle weakness.

Lifestyle & Prevention

• Maintain a balanced diet to support overall health.
• Avoid known triggers for seizures (e.g., stress, sleep deprivation).
• Engage in regular, gentle exercise as tolerated.

When to Seek Professional Help

Seek immediate care for new or worsening seizures, sudden weakness, or changes in consciousness. Routine follow-up is essential for monitoring disease progression.

Tips for Medical Coders

• Use E88.42 for MERRF syndrome. Ensure documentation supports the diagnosis, including clinical findings (e.g., myoclonus, ragged-red fibers) and genetic testing results. Differentiate from other mitochondrial disorders (e.g., MELAS) based on specific symptoms and genetic mutations.